{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T08:30:16Z","timestamp":1659429016677},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.2169\/internalmedicine.7130-21","type":"journal-article","created":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T22:06:28Z","timestamp":1618178788000},"page":"3409-3412","source":"Crossref","is-referenced-by-count":1,"title":["Malignant Peritoneal Mesothelioma with Latent Tuberculosis Infection"],"prefix":"10.2169","volume":"60","author":[{"given":"Naonori","family":"Inoue","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Takumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Sone","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Shirakawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Uno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kyoto Second Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jiang Y, Mei Z, Cao H, et al. Meningeal metastasis of a malignant peritoneal mesothelioma: a case report and literature review. Cancer Biol Ther 20: 1409-1415, 2019.","DOI":"10.1080\/15384047.2019.1647053"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology 30: 403-418, 1997.","DOI":"10.1046\/j.1365-2559.1997.5460776.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mensi C, Mendola M, Dallari B, et al. Differences between peritoneal and pleural mesothelioma in Lombardy, Italy. Cancer Epidemiol 51: 68-73, 2017.","DOI":"10.1016\/j.canep.2017.10.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sugarbaker PH, Welch LS, Mohamed F, Glehen O. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 12: 605-621, xi, 2003.","DOI":"10.1016\/S1055-3207(03)00045-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 353: 1591-1603, 2005.","DOI":"10.1056\/NEJMra050152"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 18: 985-990, 2007.","DOI":"10.1093\/annonc\/mdl345"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yu H, Zhang C, Liu S, et al. Clinical value of CT-guided percutaneous fine-needle aspiration biopsy for peritoneal lesions. BMC Med Imaging 20: 122, 2020.","DOI":"10.1186\/s12880-020-00512-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 161: S221-S247, 2000.","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yin WJ, Zheng GQ, Chen YF, et al. CT differentiation of malignant peritoneal mesothelioma and tuberculous peritonitis. Radiol Med 121: 253-260, 2016.","DOI":"10.1007\/s11547-015-0609-y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Simonsen DF, Farkas DK, S\u00f8gaard M, Horsburgh CR, S\u00f8rensen HT, Thomsen RW. Tuberculosis and risk of cancer: a Danish nationwide cohort study. Int J Tuberc Lung Dis 18: 1211-1219, 2014.","DOI":"10.5588\/ijtld.14.0161"},{"key":"11","unstructured":"11. Roviaro GC, Sartori F, Calabr\u00f2 F, Varoli F. The association of pleural mesothelioma and tuberculosis. Am Rev Respir Dis 126: 569-571, 1982."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kumar P, Chawla K, Khosla P, Jain S. Co-existing tuberculosis and malignant mesothelioma with multiple sites venous thrombosis: a case report. BMC Res Notes 9: 409, 2016.","DOI":"10.1186\/s13104-016-2215-z"},{"key":"13","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1148\/rg.226025125","volume":"22","author":"JM Busch","year":"2002","unstructured":"13. Busch JM, Kruskal JB, Wu B. Best cases from the AFIP. Malignant peritoneal mesothelioma. Radiographics 22: 1511-1515, 2002.","journal-title":"Radiographics","ISSN":"http:\/\/id.crossref.org\/issn\/0271-5333","issn-type":"print"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Levy AD, Arn\u00e1iz J, Shaw JC, Sobin LH. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics 28: 583-607; quiz 621-622, 2008.","DOI":"10.1148\/rg.282075175"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Pickhardt PJ, Bhalla S. Unusual nonneoplastic peritoneal and subperitoneal conditions: CT findings. Radiographics 25: 719-730, 2005.","DOI":"10.1148\/rg.253045145"},{"key":"16","unstructured":"16. WHO Guidelines Approved by the Guidelines Review Committee. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization, Geneva, 2018."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/21\/60_7130-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T03:19:57Z","timestamp":1636168797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/21\/60_7130-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":16,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7130-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"article-number":"7130-21"}}